@Article{chd.12712,
AUTHOR = {Myriam Almeida‐Jones, Nai Yu Tang, Aneela Reddy, Evan Zahn},
TITLE = {Overview of transcatheter patent ductus arteriosus closure in preterm infants},
JOURNAL = {Structural and Congenital Heart Disease},
VOLUME = {14},
YEAR = {2019},
NUMBER = {1},
PAGES = {60--64},
URL = {http://www.techscience.com/schd/v14n1/38745},
ISSN = {3071-1738},
ABSTRACT = {Clinically significant patent ductus arteriosus (PDA) has been associated with signifi‐
cant morbidity in extremely low birth weight (ELBW) infants. Current management of 
ELBW infants with hemodynamically significant PDA includes supportive treatment, 
pharmacological therapy, and surgical ligation. All of these therapeutic options have 
their advantages and limitations. More recently, transcatheter PDA closure has been 
described as a viable option in this population. In this paper, we provide a compre‐
hensive review of this emerging procedure.},
DOI = {10.1111/chd.12712}
}